Captopril, an FDA‐approved angiotensin‐converting enzyme (ACE) inhibitor used for the treatment of hypertension, was selected because it was reported to increase lifespan in both wildtype C. elegans and mutants that extend lifespan (Kumar et al., 2016). This evidence concerns the gene ACE and Hypertension.